COVID-19: Licensing agreement for new candidate drug ‘an important first step’
Access to a potential new COVID-19 drug will be expanded in low- and middle-income countries following a voluntary licensing agreement between the pharmaceutical company Pfizer and a UN-backed global health initiative, announced in Geneva on Tuesday.
Read Original Article: COVID-19: Licensing agreement for new candidate drug ‘an important first step’ »
